Results 11 to 20 of about 258,861 (311)
Frontiers in Cellular and Infection Microbiology, 2020 The most common bacterial cause of pharyngitis is infection by Group A β-hemolytic streptococcus (GABHS), commonly known as strep throat. 5–15% of adults and 15–35% of children in the United States with pharyngitis have a GABHS infection. The symptoms of
Zahid Mustafa, Masoumeh Ghaffari
doaj +1 more source
, 2020 Group A Streptococcus (GAS) or Streptococcus pyogenes, affects an estimated 800 million people each year. Most of the resulting estimated 639,000 annual deaths are related to rheumatic heart disease (RHD) and its complications. Resource-limited areas account for the vast majority of cases, although outbreaks still occur in industrialized countries. GAS
Hand, Robert M. +2 more
openaire +2 more sources
Annals of Clinical Microbiology, 2021 Background: Group A streptococcus (GAS) is the most common cause of bacterial pharyngitis. This study aimed to characterize the molecular epidemiology of GAS infection using an emmtyping and emm-clustering approach.
Seon A Jo, Seungjun Lee, Sunjoo Kim
doaj +1 more source
Canadian Medical Association Journal, 2015 It was gratifying to read that the authors of this commentary[1][1] on group A streptococcus mention the significant rate of colonization versus infection. Surprisingly, this was not mentioned in the related research article.[2][2] This continuing uncertainty, so appropriate in science ...
openaire +2 more sources
Correlates of Protection for M Protein-Based Vaccines against Group A Streptococcus
Journal of Immunology Research, 2015 Group A streptococcus (GAS) is known to cause a broad spectrum of illness, from pharyngitis and impetigo, to autoimmune sequelae such as rheumatic heart disease, and invasive diseases.
Shu Ki Tsoi +4 more
doaj +1 more source
GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A Streptococcus
Vaccines, 2022 Group A Streptococcus (GAS) causes about 500,000 annual deaths globally, and no vaccines are currently available. The Group A Carbohydrate (GAC), conserved across all GAS serotypes, conjugated to an appropriate carrier protein, represents a promising ...
Elena Palmieri +14 more
doaj +1 more source
Streptococcus pyogenes and re-emergence of scarlet fever as a public health problem
Emerging Microbes and Infections, 2012 Explosive outbreaks of infectious diseases occasionally occur without immediately obvious epidemiological or microbiological explanations. Plague, cholera and Streptococcus pyogenes infection are some of the epidemic-prone bacterial infections.
Samson SY Wong, Kwok-Yung Yuen
doaj +1 more source
Emerging Infectious Diseases, 2019 The risk for invasive streptococcal infection has not been clearly quantified among persons experiencing homelessness (PEH). We compared the incidence of detected cases of invasive group A Streptococcus infection, group B Streptococcus infection, and ...
Emily Mosites +9 more
doaj +1 more source
Streptococcus difficile is a nonhemolytic group B, type Ib streptococcus [PDF]
International Journal of Systematic Bacteriology, 1997 Whole-cell protein electrophoretic analysis of the type strain of Streptococcus difficile (LMG 15799) revealed that this organism was indistinguishable from Streptococcus agalactiae strains. Although LMG 15799T (T = type strain) was originally described as serologically untypeable, we found that this strain was a group B streptococcus belonging to the ...
Vandamme, Peter +4 more
openaire +5 more sources
Effects of Streptococcal Pyrogenic Exotoxin B on Pathogenesis of Streptococcus pyogenes
Journal of the Formosan Medical Association, 2008 Streptococcus pyogenes (group A streptococcus, GAS) is a ubiquitous and important human bacterial pathogen. This organism possesses several virulence factors to establish infection.
Chuan Chiang-Ni, Jiunn-Jong Wu
doaj +1 more source